University of Bonn

Overview

The Bonn International Graduate School of Drug Sciences (BIGS DrugS) offers a comprehensive PhD training programme at the University of Bonn. Designed to span three years, this structured programme integrates individual research projects with an extensive educational framework that includes workshops, lectures, and scientific events.

What you'll study

BIGS DrugS combines rigorous academic training with innovative research in drug discovery and therapeutic development across various biomedical disciplines. The core components of the programme include:

• Individual PhD research project: Engage in an original research project within one of the dedicated research groups at the University of Bonn.
• Education programme: Participate in a variety of workshops, lectures, colloquia, and symposia designed to enhance both scientific knowledge and professional skills.
• Scientific exchange: Take part in regular presentations and discussion forums to foster effective research communication and networking opportunities.

Research areas

• Pharmacy and pharmaceutical sciences
• Pharmacology
• Cell and molecular biology
• Biochemistry
• Neurosciences
• Physiology

Training outcomes

• Acquire expertise in drug targets, lead discovery, optimization, and the development of therapeutic concepts.
• Enhance experimental and analytical skills pertinent to biomedical research.
• Refine presentation and scientific writing capabilities through various programme activities and research reporting.

Entry requirements

Prospective applicants should hold a relevant university degree, such as a Master’s or an equivalent qualification, in a biomedical, pharmaceutical, or closely related field. While specific grading criteria and standardized tests are not mandated for admission, a solid academic foundation is essential for success in the programme.

Career prospects

Graduates of the BIGS DrugS programme are well-prepared for a range of career paths in academia, industry, and research institutions. With a strong emphasis on drug research and development, alumni often pursue roles in pharmaceutical companies, regulatory agencies, and academic research, contributing significantly to advancements in healthcare and medicine.